miRNA-Dependent CD4+ T Cell Differentiation in the Pathogenesis of Multiple Sclerosis
Multiple sclerosis (MS) is characterized by multifocal lesions, chronic inflammatory condition, and degenerative processes within the central nervous system (CNS) leading to demyelination. The most important cells involved in its pathogenesis are those which are CD4+, particularly proinflammatory Th...
Uložené v:
| Vydané v: | Multiple sclerosis international Ročník 2021; s. 1 - 11 |
|---|---|
| Hlavní autori: | , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Egypt
Hindawi
08.01.2021
John Wiley & Sons, Inc |
| Predmet: | |
| ISSN: | 2090-2654, 2090-2662 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Multiple sclerosis (MS) is characterized by multifocal lesions, chronic inflammatory condition, and degenerative processes within the central nervous system (CNS) leading to demyelination. The most important cells involved in its pathogenesis are those which are CD4+, particularly proinflammatory Th1/Th17 and regulatory Treg. Signal cascades associated with CD4+ differentiation are regulated by microRNAs (miRNAs): short, single-stranded RNAs, responsible for negative regulation of gene expression at the posttranscriptional level. Several miRNAs have been consistently reported as showing dysregulated expression in MS, and their expression patterns may be elevated or decreased, depending on the function of specific miRNA in the immune system. Studies in MS patients indicate that, among others, miR-141, miR-200a, miR-155, miR-223, and miR-326 are upregulated, while miR-15b, miR-20b, miR-26a, and miR-30a are downregulated. Dysregulation of these miRNAs may contribute to the imbalance between pro- and anti-inflammatory processes, since their targets are associated with the regulation of Th1/Th17 and Treg cell differentiation. Highly expressed miRNAs can in turn suppress translation of key Th1/Th17 differentiation inhibitors. miRNA dysregulation may result from the impact of various factors at each stage of their biogenesis. Immature miRNA undergoes multistage transcriptional and posttranscriptional modifications; therefore, any protein involved in the processing of miRNAs can potentially lead to disturbances in their expression. Epigenetic modifications that have a direct impact on miRNA gene transcription may also play an important role. |
|---|---|
| AbstractList | Multiple sclerosis (MS) is characterized by multifocal lesions, chronic inflammatory condition, and degenerative processes within the central nervous system (CNS) leading to demyelination. The most important cells involved in its pathogenesis are those which are CD4[sup.+], particularly proinflammatory Th1/Th17 and regulatory Treg. Signal cascades associated with CD4[sup.+] differentiation are regulated by microRNAs (miRNAs): short, single-stranded RNAs, responsible for negative regulation of gene expression at the posttranscriptional level. Several miRNAs have been consistently reported as showing dysregulated expression in MS, and their expression patterns may be elevated or decreased, depending on the function of specific miRNA in the immune system. Studies in MS patients indicate that, among others, miR-141, miR-200a, miR-155, miR-223, and miR-326 are upregulated, while miR-15b, miR-20b, miR-26a, and miR-30a are downregulated. Dysregulation of these miRNAs may contribute to the imbalance between pro- and anti-inflammatory processes, since their targets are associated with the regulation of Th1/Th17 and Treg cell differentiation. Highly expressed miRNAs can in turn suppress translation of key Th1/Th17 differentiation inhibitors. miRNA dysregulation may result from the impact of various factors at each stage of their biogenesis. Immature miRNA undergoes multistage transcriptional and posttranscriptional modifications; therefore, any protein involved in the processing of miRNAs can potentially lead to disturbances in their expression. Epigenetic modifications that have a direct impact on miRNA gene transcription may also play an important role. Multiple sclerosis (MS) is characterized by multifocal lesions, chronic inflammatory condition, and degenerative processes within the central nervous system (CNS) leading to demyelination. The most important cells involved in its pathogenesis are those which are CD4+, particularly proinflammatory Th1/Th17 and regulatory Treg. Signal cascades associated with CD4+ differentiation are regulated by microRNAs (miRNAs): short, single-stranded RNAs, responsible for negative regulation of gene expression at the posttranscriptional level. Several miRNAs have been consistently reported as showing dysregulated expression in MS, and their expression patterns may be elevated or decreased, depending on the function of specific miRNA in the immune system. Studies in MS patients indicate that, among others, miR-141, miR-200a, miR-155, miR-223, and miR-326 are upregulated, while miR-15b, miR-20b, miR-26a, and miR-30a are downregulated. Dysregulation of these miRNAs may contribute to the imbalance between pro- and anti-inflammatory processes, since their targets are associated with the regulation of Th1/Th17 and Treg cell differentiation. Highly expressed miRNAs can in turn suppress translation of key Th1/Th17 differentiation inhibitors. miRNA dysregulation may result from the impact of various factors at each stage of their biogenesis. Immature miRNA undergoes multistage transcriptional and posttranscriptional modifications; therefore, any protein involved in the processing of miRNAs can potentially lead to disturbances in their expression. Epigenetic modifications that have a direct impact on miRNA gene transcription may also play an important role. Multiple sclerosis (MS) is characterized by multifocal lesions, chronic inflammatory condition, and degenerative processes within the central nervous system (CNS) leading to demyelination. The most important cells involved in its pathogenesis are those which are CD4+, particularly proinflammatory Th1/Th17 and regulatory Treg. Signal cascades associated with CD4+ differentiation are regulated by microRNAs (miRNAs): short, single-stranded RNAs, responsible for negative regulation of gene expression at the posttranscriptional level. Several miRNAs have been consistently reported as showing dysregulated expression in MS, and their expression patterns may be elevated or decreased, depending on the function of specific miRNA in the immune system. Studies in MS patients indicate that, among others, miR-141, miR-200a, miR-155, miR-223, and miR-326 are upregulated, while miR-15b, miR-20b, miR-26a, and miR-30a are downregulated. Dysregulation of these miRNAs may contribute to the imbalance between pro- and anti-inflammatory processes, since their targets are associated with the regulation of Th1/Th17 and Treg cell differentiation. Highly expressed miRNAs can in turn suppress translation of key Th1/Th17 differentiation inhibitors. miRNA dysregulation may result from the impact of various factors at each stage of their biogenesis. Immature miRNA undergoes multistage transcriptional and posttranscriptional modifications; therefore, any protein involved in the processing of miRNAs can potentially lead to disturbances in their expression. Epigenetic modifications that have a direct impact on miRNA gene transcription may also play an important role.Multiple sclerosis (MS) is characterized by multifocal lesions, chronic inflammatory condition, and degenerative processes within the central nervous system (CNS) leading to demyelination. The most important cells involved in its pathogenesis are those which are CD4+, particularly proinflammatory Th1/Th17 and regulatory Treg. Signal cascades associated with CD4+ differentiation are regulated by microRNAs (miRNAs): short, single-stranded RNAs, responsible for negative regulation of gene expression at the posttranscriptional level. Several miRNAs have been consistently reported as showing dysregulated expression in MS, and their expression patterns may be elevated or decreased, depending on the function of specific miRNA in the immune system. Studies in MS patients indicate that, among others, miR-141, miR-200a, miR-155, miR-223, and miR-326 are upregulated, while miR-15b, miR-20b, miR-26a, and miR-30a are downregulated. Dysregulation of these miRNAs may contribute to the imbalance between pro- and anti-inflammatory processes, since their targets are associated with the regulation of Th1/Th17 and Treg cell differentiation. Highly expressed miRNAs can in turn suppress translation of key Th1/Th17 differentiation inhibitors. miRNA dysregulation may result from the impact of various factors at each stage of their biogenesis. Immature miRNA undergoes multistage transcriptional and posttranscriptional modifications; therefore, any protein involved in the processing of miRNAs can potentially lead to disturbances in their expression. Epigenetic modifications that have a direct impact on miRNA gene transcription may also play an important role. Multiple sclerosis (MS) is characterized by multifocal lesions, chronic inflammatory condition, and degenerative processes within the central nervous system (CNS) leading to demyelination. The most important cells involved in its pathogenesis are those which are CD4 , particularly proinflammatory Th1/Th17 and regulatory Treg. Signal cascades associated with CD4 differentiation are regulated by microRNAs (miRNAs): short, single-stranded RNAs, responsible for negative regulation of gene expression at the posttranscriptional level. Several miRNAs have been consistently reported as showing dysregulated expression in MS, and their expression patterns may be elevated or decreased, depending on the function of specific miRNA in the immune system. Studies in MS patients indicate that, among others, miR-141, miR-200a, miR-155, miR-223, and miR-326 are upregulated, while miR-15b, miR-20b, miR-26a, and miR-30a are downregulated. Dysregulation of these miRNAs may contribute to the imbalance between pro- and anti-inflammatory processes, since their targets are associated with the regulation of Th1/Th17 and Treg cell differentiation. Highly expressed miRNAs can in turn suppress translation of key Th1/Th17 differentiation inhibitors. miRNA dysregulation may result from the impact of various factors at each stage of their biogenesis. Immature miRNA undergoes multistage transcriptional and posttranscriptional modifications; therefore, any protein involved in the processing of miRNAs can potentially lead to disturbances in their expression. Epigenetic modifications that have a direct impact on miRNA gene transcription may also play an important role. |
| Audience | Academic |
| Author | Basak, Justyna Majsterek, Ireneusz |
| AuthorAffiliation | Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, Lodz, Poland |
| AuthorAffiliation_xml | – name: Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, Lodz, Poland |
| Author_xml | – sequence: 1 givenname: Justyna orcidid: 0000-0003-4496-7232 surname: Basak fullname: Basak, Justyna organization: Department of Clinical Chemistry and BiochemistryMedical University of LodzLodzPolandumed.pl – sequence: 2 givenname: Ireneusz orcidid: 0000-0001-6231-3334 surname: Majsterek fullname: Majsterek, Ireneusz organization: Department of Clinical Chemistry and BiochemistryMedical University of LodzLodzPolandumed.pl |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33505725$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkt9v0zAQxyM0xMbYG88oEhJCGtlsJ46dF6Sq5Zc0fgi2Z8t1Lo0n1-7iBMR_z4V2o52gIn6Idf7c17677-PkwAcPSfKUkjNKOT9nhNFzKRnnUj5IjhipSMbKkh3c7XlxmJzEeE3w44QJmT9KDvOcEy4YP0qulvbrp0k2gxX4GnyfTmfFaXqZTsG5dGabBjqMWt3b4FPr076F9Ivu27AAD9HGNDTpx8H1duUg_WYcdAGjT5KHjXYRTjb_4-Tq7ZvL6fvs4vO7D9PJRWa4KPqsoYIVGgylTLC5NkyYQgpRVwbLASlkTeuyqMkccs0qqqmoS0JLAo0wZk5Ffpy8XuuuhvkSaoNP7bRTq84udfdTBW3V7om3rVqE70pISnhJUeDlRqALNwPEXi1tNFi79hCGqFghsZ0l5zmiz--h12HoPJaHFLYV-0noH2qhHSjrm4D3mlFUTcqqFKyUFdtPoVTBWD5SZ3-hcNWwtAaN0FiM78j-X8LWDS-2ElrQrm9jcMM47birvB_cUny2PZG7Udw6DgG2Bgw6JXbQKGP73_bCt1qnKFGjs9XobLVxNia9upd0q_sP_HSNt9bX-ofdT_8CYfP-0Q |
| CitedBy_id | crossref_primary_10_1186_s12964_022_01019_7 crossref_primary_10_4103_1673_5374_346462 crossref_primary_10_1007_s12035_021_02622_4 crossref_primary_10_3389_fimmu_2024_1442694 crossref_primary_10_3389_fnmol_2022_865529 crossref_primary_10_1007_s11033_023_08812_8 |
| Cites_doi | 10.1172/JCI94012 10.1038/nature04753 10.1523/JNEUROSCI.4794-14.2015 10.1038/ni1507 10.1093/brain/awp289 10.3389/fgene.2013.00258 10.7554/eLife.05005 10.1038/cdd.2014.112 10.1093/brain/awr262 10.1007/s12017-014-8335-5 10.1126/science.1102513 10.1016/j.cell.2006.07.035 10.1038/nature05841 10.1146/annurev.immunol.021908.132710 10.1515/bmc-2017-0024 10.4049/jimmunol.165.11.6107 10.2353/ajpath.2008.070690 10.4049/jimmunol.178.8.4901 10.1016/j.bbi.2016.03.016 10.1523/JNEUROSCI.2830-15.2015 10.1056/NEJMra052130 10.1016/j.molcel.2014.09.004 10.1006/jaut.2001.0520 10.3233/NRE-2009-0525 10.7554/eLife.56916 10.1186/1742-2094-10-35 10.1093/emboj/cdf648 10.1073/pnas.1114325109 10.1111/imm.12611 10.1016/j.molimm.2014.10.001 10.1101/gad.1706508 10.1111/j.1365-2249.2010.04143.x 10.1016/j.ygeno.2007.01.004 10.1002/eji.201444667 10.1038/nature04754 10.1371/journal.pone.0124555 10.1038/ni1254 10.1016/j.immuni.2010.09.009 10.1101/gr.2722704 10.4161/cc.6.9.4209 10.1038/s41467-019-13527-1 10.1016/S0092-8674(00)80702-3 10.1074/jbc.M111.337154 10.1002/path.2251 10.1016/j.ccr.2007.09.020 10.1084/jem.20081219 10.4049/jimmunol.177.1.566 10.4049/jimmunol.1501965 10.3389/fimmu.2017.00531 10.1016/j.immuni.2016.05.015 10.1186/s12974-017-0832-7 10.3389/fimmu.2019.00015 10.1016/j.cell.2004.12.035 10.1038/nature05970 10.3390/ijms17101712 10.1016/j.jneuroim.2012.02.012 10.1172/JCI74347 10.4049/jimmunol.1300351 10.1002/ana.23967 10.1172/JCI31720 10.1155/2016/1720827 10.1038/ni.1899 10.1093/nar/gky1141 10.1080/08916934.2019.1710135 10.1016/j.immuni.2008.11.010 10.1186/gb-2013-14-8-r84 10.4049/jimmunol.1601727 10.1038/nri3494 10.4049/jimmunol.1303488 10.1016/j.immuni.2006.01.001 10.1016/j.jaci.2017.08.034 10.1074/jbc.C600321200 10.1096/fj.09-141978 10.1002/ijc.28237 10.18632/oncotarget.20214 10.1002/eji.200940032 10.4049/jimmunol.1003952 10.1002/eji.201242702 10.1016/j.bbrc.2013.03.022 10.1055/s-0038-1660819 10.1002/art.23386 10.1038/ni794 10.1016/j.immuni.2007.11.016 10.1084/jem.20041257 10.1038/ni.1798 10.1016/j.jns.2017.11.014 10.1038/embor.2008.224 10.1158/0008-5472.CAN-05-3632 10.1016/j.jocn.2014.06.106 10.1261/rna.1731910 10.1126/science.aav1741 10.1084/jem.20050678 10.3389/fimmu.2017.01160 |
| ContentType | Journal Article |
| Copyright | Copyright © 2021 Justyna Basak and Ireneusz Majsterek. COPYRIGHT 2021 John Wiley & Sons, Inc. Copyright © 2021 Justyna Basak and Ireneusz Majsterek. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2021 Justyna Basak and Ireneusz Majsterek. 2021 |
| Copyright_xml | – notice: Copyright © 2021 Justyna Basak and Ireneusz Majsterek. – notice: COPYRIGHT 2021 John Wiley & Sons, Inc. – notice: Copyright © 2021 Justyna Basak and Ireneusz Majsterek. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2021 Justyna Basak and Ireneusz Majsterek. 2021 |
| DBID | RHU RHW RHX AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.1155/2021/8825588 |
| DatabaseName | Hindawi Publishing Complete Hindawi Publishing Subscription Journals Hindawi Publishing Open Access CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest One Health & Nursing ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed Publicly Available Content Database CrossRef |
| Database_xml | – sequence: 1 dbid: RHX name: Hindawi Publishing Open Access url: http://www.hindawi.com/journals/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health |
| EISSN | 2090-2662 |
| Editor | Stangel, Martin |
| Editor_xml | – sequence: 1 givenname: Martin surname: Stangel fullname: Stangel, Martin |
| EndPage | 11 |
| ExternalDocumentID | PMC7810561 A696726892 A683542232 33505725 10_1155_2021_8825588 |
| Genre | Journal Article Review |
| GrantInformation_xml | – fundername: Uniwersytet Medyczny w Lodzi – fundername: Narodowe Centrum Nauki grantid: 2017/27/B/NZ7/02527 |
| GroupedDBID | --- 188 4.4 53G 5VS 7X7 8FI 8FJ AAFWJ AAJEY ABDBF ABUWG ADBBV ADRAZ AFKRA AFPKN AINHJ ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV BENPR CCPQU EBD EBS ESX FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IEA IHR IHW ITC KQ8 M48 M~E OK1 PIMPY RHU RHW RHX RNS RPM TUS UKHRP 0R~ 24P AAMMB AAYXX ACCMX ACUHS AEFGJ AFFHD AGXDD AIDQK AIDYY ALUQN CITATION H13 PGMZT PHGZM PHGZT 2UF ALIPV CEFSP CNMHZ EJD IL9 NPM UZ5 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c574t-f1724aec11272bac27c4877d9c588e878d1d64d0be3a291a17d60160ef7ccb173 |
| IEDL.DBID | RHX |
| ISICitedReferencesCount | 23 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000609968300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2090-2654 |
| IngestDate | Tue Nov 04 01:55:54 EST 2025 Thu Oct 02 05:54:58 EDT 2025 Tue Oct 07 07:00:16 EDT 2025 Tue Nov 11 10:55:12 EST 2025 Tue Nov 11 10:56:06 EST 2025 Tue Nov 04 18:15:46 EST 2025 Tue Nov 04 18:17:29 EST 2025 Thu May 22 21:27:00 EDT 2025 Thu May 22 21:26:58 EDT 2025 Wed Feb 19 02:29:15 EST 2025 Sat Nov 29 02:54:09 EST 2025 Tue Nov 18 21:49:24 EST 2025 Sun Jun 02 18:51:52 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0 Copyright © 2021 Justyna Basak and Ireneusz Majsterek. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c574t-f1724aec11272bac27c4877d9c588e878d1d64d0be3a291a17d60160ef7ccb173 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 Academic Editor: Martin Stangel |
| ORCID | 0000-0001-6231-3334 0000-0003-4496-7232 |
| OpenAccessLink | https://dx.doi.org/10.1155/2021/8825588 |
| PMID | 33505725 |
| PQID | 2478357201 |
| PQPubID | 4727247 |
| PageCount | 11 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7810561 proquest_miscellaneous_2482666553 proquest_journals_2478357201 gale_infotracmisc_A696726892 gale_infotracmisc_A683542232 gale_infotracacademiconefile_A696726892 gale_infotracacademiconefile_A683542232 gale_healthsolutions_A696726892 gale_healthsolutions_A683542232 pubmed_primary_33505725 crossref_citationtrail_10_1155_2021_8825588 crossref_primary_10_1155_2021_8825588 hindawi_primary_10_1155_2021_8825588 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-01-08 |
| PublicationDateYYYYMMDD | 2021-01-08 |
| PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-08 day: 08 |
| PublicationDecade | 2020 |
| PublicationPlace | Egypt |
| PublicationPlace_xml | – name: Egypt – name: New York |
| PublicationTitle | Multiple sclerosis international |
| PublicationTitleAlternate | Mult Scler Int |
| PublicationYear | 2021 |
| Publisher | Hindawi John Wiley & Sons, Inc |
| Publisher_xml | – name: Hindawi – name: John Wiley & Sons, Inc |
| References | 44 C. E. McCoy (59) 2017 88 45 89 46 47 48 49 90 91 92 93 50 94 51 95 52 96 53 10 54 11 55 12 56 13 57 14 58 16 17 18 19 1 2 3 4 5 6 7 8 9 60 61 62 63 20 64 21 65 22 66 23 67 24 68 25 69 26 27 28 29 K. M. Pollard (15) 2013; 16 70 71 72 73 30 74 31 75 32 76 33 77 34 78 35 79 37 38 39 R. Feinbaum (36) 2004; 116 80 81 82 83 40 84 41 85 42 86 43 87 |
| References_xml | – ident: 69 doi: 10.1172/JCI94012 – ident: 29 doi: 10.1038/nature04753 – ident: 95 doi: 10.1523/JNEUROSCI.4794-14.2015 – ident: 1 doi: 10.1038/ni1507 – ident: 22 doi: 10.1093/brain/awp289 – volume: 116 start-page: 843 issue: 116 year: 2004 ident: 36 article-title: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 publication-title: Cell – ident: 81 doi: 10.3389/fgene.2013.00258 – ident: 89 doi: 10.7554/eLife.05005 – ident: 94 doi: 10.1038/cdd.2014.112 – ident: 7 doi: 10.1093/brain/awr262 – ident: 50 doi: 10.1007/s12017-014-8335-5 – ident: 93 doi: 10.1126/science.1102513 – ident: 33 doi: 10.1016/j.cell.2006.07.035 – ident: 91 doi: 10.1038/nature05841 – ident: 25 doi: 10.1146/annurev.immunol.021908.132710 – ident: 74 doi: 10.1515/bmc-2017-0024 – ident: 21 doi: 10.4049/jimmunol.165.11.6107 – ident: 27 doi: 10.2353/ajpath.2008.070690 – ident: 32 doi: 10.4049/jimmunol.178.8.4901 – ident: 68 doi: 10.1016/j.bbi.2016.03.016 – ident: 61 doi: 10.1523/JNEUROSCI.2830-15.2015 – ident: 10 doi: 10.1056/NEJMra052130 – ident: 92 doi: 10.1016/j.molcel.2014.09.004 – ident: 14 doi: 10.1006/jaut.2001.0520 – ident: 3 doi: 10.3233/NRE-2009-0525 – ident: 53 doi: 10.7554/eLife.56916 – ident: 4 doi: 10.1186/1742-2094-10-35 – ident: 20 doi: 10.1093/emboj/cdf648 – ident: 54 doi: 10.1073/pnas.1114325109 – ident: 66 doi: 10.1111/imm.12611 – ident: 70 doi: 10.1016/j.molimm.2014.10.001 – ident: 73 doi: 10.1101/gad.1706508 – ident: 11 doi: 10.1111/j.1365-2249.2010.04143.x – ident: 96 doi: 10.1016/j.ygeno.2007.01.004 – ident: 67 doi: 10.1002/eji.201444667 – ident: 28 doi: 10.1038/nature04754 – ident: 43 doi: 10.1371/journal.pone.0124555 – ident: 16 doi: 10.1038/ni1254 – ident: 62 doi: 10.1016/j.immuni.2010.09.009 – ident: 72 doi: 10.1101/gr.2722704 – ident: 77 doi: 10.4161/cc.6.9.4209 – ident: 79 doi: 10.1038/s41467-019-13527-1 – ident: 18 doi: 10.1016/S0092-8674(00)80702-3 – ident: 57 doi: 10.1074/jbc.M111.337154 – ident: 78 doi: 10.1002/path.2251 – ident: 84 doi: 10.1016/j.ccr.2007.09.020 – ident: 86 doi: 10.1084/jem.20081219 – volume: 16 start-page: 123 issue: 87 year: 2013 ident: 15 article-title: Interferon-γ and systemic autoimmunity publication-title: Discovery Medicine – ident: 24 doi: 10.4049/jimmunol.177.1.566 – ident: 46 doi: 10.4049/jimmunol.1501965 – ident: 5 doi: 10.3389/fimmu.2017.00531 – ident: 52 doi: 10.1016/j.immuni.2016.05.015 – ident: 56 doi: 10.1186/s12974-017-0832-7 – ident: 9 doi: 10.3389/fimmu.2019.00015 – ident: 38 doi: 10.1016/j.cell.2004.12.035 – ident: 31 doi: 10.1038/nature05970 – ident: 88 doi: 10.3390/ijms17101712 – ident: 71 doi: 10.1016/j.jneuroim.2012.02.012 – ident: 65 doi: 10.1172/JCI74347 – ident: 45 doi: 10.4049/jimmunol.1300351 – ident: 60 doi: 10.1002/ana.23967 – ident: 13 doi: 10.1172/JCI31720 – ident: 35 doi: 10.1155/2016/1720827 – ident: 12 doi: 10.1038/ni.1899 – ident: 37 doi: 10.1093/nar/gky1141 – ident: 40 doi: 10.1080/08916934.2019.1710135 – ident: 63 doi: 10.1016/j.immuni.2008.11.010 – ident: 75 doi: 10.1186/gb-2013-14-8-r84 – ident: 48 doi: 10.4049/jimmunol.1601727 – ident: 39 doi: 10.1038/nri3494 – ident: 49 doi: 10.4049/jimmunol.1303488 – ident: 23 doi: 10.1016/j.immuni.2006.01.001 – ident: 8 doi: 10.1016/j.jaci.2017.08.034 – ident: 17 doi: 10.1074/jbc.C600321200 – ident: 26 doi: 10.1096/fj.09-141978 – ident: 51 doi: 10.1002/ijc.28237 – ident: 80 doi: 10.18632/oncotarget.20214 – ident: 42 doi: 10.1002/eji.200940032 – start-page: 111 volume-title: Advances in Experimental Medicine and Biology year: 2017 ident: 59 article-title: miR-155 dysregulation and therapeutic intervention in multiple sclerosis – ident: 64 doi: 10.4049/jimmunol.1003952 – ident: 41 doi: 10.1002/eji.201242702 – ident: 83 doi: 10.1016/j.bbrc.2013.03.022 – ident: 2 doi: 10.1055/s-0038-1660819 – ident: 58 doi: 10.1002/art.23386 – ident: 19 doi: 10.1038/ni794 – ident: 34 doi: 10.1016/j.immuni.2007.11.016 – ident: 30 doi: 10.1084/jem.20041257 – ident: 47 doi: 10.1038/ni.1798 – ident: 44 doi: 10.1016/j.jns.2017.11.014 – ident: 55 doi: 10.1038/embor.2008.224 – ident: 82 doi: 10.1158/0008-5472.CAN-05-3632 – ident: 87 doi: 10.1016/j.jocn.2014.06.106 – ident: 76 doi: 10.1261/rna.1731910 – ident: 90 doi: 10.1126/science.aav1741 – ident: 85 doi: 10.1084/jem.20050678 – ident: 6 doi: 10.3389/fimmu.2017.01160 |
| SSID | ssj0000502783 |
| Score | 2.2725384 |
| SecondaryResourceType | review_article |
| Snippet | Multiple sclerosis (MS) is characterized by multifocal lesions, chronic inflammatory condition, and degenerative processes within the central nervous system... |
| SourceID | pubmedcentral proquest gale pubmed crossref hindawi |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1 |
| SubjectTerms | Autoimmune diseases B cells Cell differentiation Cell growth Cytokines Epigenetic inheritance Epigenetics Gene expression Genes Genetic transcription Immune system Inflammation Lymphocytes Medical research Medicine, Experimental MicroRNA MicroRNAs Multiple sclerosis Pathogenesis Pathogens Review T cells Tumor necrosis factor-TNF |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9QwDI_gBtIkxPdG4YAgDfEwVWvTpGmf0HG3iQc4ncYm7a1qk5RVurVj7di_P7vN9Sja2APP-TVpYjuxHccmZIdnvtBRELhKqdzlMYhUptPYzaSXsZQFOU_bJK7f5HwenZzEC-twq21Y5WpPbDdqXSn0ke8xjj4KCefV5_NfLlaNwttVW0LjPtnATGV8RDa-7M8Xh72XxRN4s4bXzMyLPZeFgq-i34VAw9_fAxVTiLbwyvpcsrvzw1O0i6-Km7TPv4Mo_ziVDp7873yeksdWH6WTjoGekXumfE4edc482r1RekGOz4rD-cSd2YK5DZ3O-C49olOzXNKZLbHSdESmRUlBqaQLUC2rn7iTFjWtcvrdRi7SHzAOLEFRvyTHB_tH06-urcfgKiF54-ag7PDUKFDRJMtSxaQCc0fqWMH6mUhG2tch115mgpTFfupLjclePJNLpTJfBltkVFaleUWo1mGkIoEPezVXimUeIEwK2iroOyKLHbK7okaibLJyrJmxTFqjRYgEaZdY2jnkY48-75J03IJ7j4RNuiemvWwnkxDdX6AosdsRcShZGMWA-NQiUP7hj1RqnzHAvDCT1qCvu5DrPscDJEi4GnR0Y_P66x3Lp3dMfrxixMTuU3Wy5kKHfOibcQCMvStNdYkYMEHDUIjAIdsdz_cDBQEauEw4RA6koQdg9vJhS1mctlnMZeSj9fr637_1hmziJFqnVzQmo-bi0rwlD9Tvpqgv3llxvwYuGVhy priority: 102 providerName: ProQuest |
| Title | miRNA-Dependent CD4+ T Cell Differentiation in the Pathogenesis of Multiple Sclerosis |
| URI | https://dx.doi.org/10.1155/2021/8825588 https://www.ncbi.nlm.nih.gov/pubmed/33505725 https://www.proquest.com/docview/2478357201 https://www.proquest.com/docview/2482666553 https://pubmed.ncbi.nlm.nih.gov/PMC7810561 |
| Volume | 2021 |
| WOSCitedRecordID | wos000609968300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2090-2662 dateEnd: 20240131 omitProxy: false ssIdentifier: ssj0000502783 issn: 2090-2654 databaseCode: 7X7 dateStart: 20130101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2090-2662 dateEnd: 20240131 omitProxy: false ssIdentifier: ssj0000502783 issn: 2090-2654 databaseCode: BENPR dateStart: 20130101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2090-2662 dateEnd: 20240131 omitProxy: false ssIdentifier: ssj0000502783 issn: 2090-2654 databaseCode: PIMPY dateStart: 20130101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 2090-2662 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000502783 issn: 2090-2654 databaseCode: 24P dateStart: 20100101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELboAAkJIX4TKMVIQzxM0RInjp3H0m4aEquisknlKUpsh0UqKVoy-Pe5S9yMjE3jpVHlL3Zs39nfne0zIbth7nMtg8BVShVuGINK5TqL3Vx4OctYUIRZG8T1i1gs5GoVJzZIUv3vEj7Mdmie-_tABDmXckRGkqPwLo9WvSvF47h8hmvJzIs9l0U83G5xv_L6YPKxQ_D9MzR-f5fXUcyrOyX_mnoOH5NHljPSadfJT8gdUz0lDzuHG-3OET0jpz_K5WLqzu2ltg2dzcM9ekJnZr2mc3sNStN1BC0rCsSPJkD_Nt9xtCtruinosd1dSL9COVCDsn5OTg8PTmZHrr0zwVVchI1bACEJM6OARgmWZ4oJBSaJ0LGC6hsppPZ1FGovN0HGYj_zhcaALJ4phFK5L4IXZKfaVOYVoVpHUkmOh291qBTLPUCYDBglcBKexw7Z2zZmqmxAcbzXYp22hgXnKTZ9apveIR969M8ukMYNuHfYL2l3DLTXv3QaoYsKyAy7GRFHgkUyBsTHFoE6Cl-kMnvUAOqF0a4Ged2GvMxzPECCFqpBRtcmX769a8XslsqPtzKY2rGkTlmI3jkBTM0h7_tkLAD3x1Vmc4EYMBOjiPPAIS87ke0LCgI0Qhl3iBgIcw_ACOPDlKo8ayONC-mjhfn6_77-DXmAf1sHlRyTneb8wrwl99SvpqzPJ2QkVqL9lRNy99PBIlnCM_l8nHybtPr8B87QO4o |
| linkProvider | Hindawi Publishing |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3Nb9MwFLfGAIGE-B4ECjPSJg5TtMSJY-eAUNUybVpXTdBJvYXEdlmkLh1rxsQ_xd_Ie4mTUrSx0w6c_YsdJ-_bz-8RshFmPtcyCFyl1MQNY2CpTKexmwkvYykLJmFaFXEdiOFQjsfx4Qr51dyFwbTKRiZWglrPFMbIt1mIMQoB-urj6XcXu0bh6WrTQqMmi33z8wJctvmHvT78303Gdj6Neruu7SrgKi7C0p2Ayg5To8DQECxLFRMKjHahY8WlNFJI7eso1F5mgpTFfuoLjSVLPDMRSmW-CGDeW-Q2yHGBKWRiLNqYjsfxHA8PtZkXey6LeNjk2nOOYQZ_Gwxazqs2LwstaHXB3WP0wi_yy2zdv1M2_9CBO4_-t6_3mDy01jbt1uzxhKyY4il5UIcqaX0D6xk5Osk_D7tu37YDLmmvH27REe2Z6ZT2bQOZsiZhmhcUTGZ6CIbz7BvqiXxOZxN6YPMy6RdYBz55Pn9Ojm5kZ2tktZgV5iWhWkdSSY7XlnWoFMs8QJgUbHGw5ngWO2Sr-fuJsqXYsSPINKlcMs4TpJXE0opDNlv0aV2C5ArcOhJSUl-gbSVX0o0wuAdmILsaEUeCRTIGxPsKgdIN3kil9pIG7AvrhC3NdR1yMWdnCQnySy1NdOnw4ukNyxfXbL7TEH5ipfA8WVC9Q961w7gAZhYWZnaOGHCwo4jzwCEvah5rFwoCdN8Zd4hY4r4WgLXZl0eK_Liq0S6kj775q3-_1jq5tzs6GCSDveH-a3IfN1SF92SHrJZn5-YNuaN-lPn87G0laCj5etO8-Ruud7Oy |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3db9MwELfGBhMS4vujUJiRNvEwRU0cO04eEKpaKqptVQWbtD2FxHa2SCUda8fEv8Zfx13ipBRt7GkPPPtix8l9_O58viNkk6ee0KHvO0qpzOERiFSqk8hJpZuyhPkZT8oirrtyNAoPD6PxCvlV34XBtMpaJ5aKWk8Vxsg7jGOMQoK96mQ2LWLcH3w4_e5gByk8aa3baVQssmN-XoD7Nns_7MO_3mJs8HG_98mxHQYcJSSfOxmYb54YBaBDsjRRTCoA8FJHSoShCWWoPR1w7abGT1jkJZ7UWL7ENZlUKvWkD_PeImsAyTnI2Np4uDc-aiI8rsBTPTziZm7kOiwQvM68FwKDDl4H4K0QZdOXhU20luHOCfrkF_llyPfvBM4_LOLgwf_8LR-S-xaH024lOI_Iiikek3tVEJNWd7OekINv-edR1-nbRsFz2uvzbbpPe2YyoX3bWmZeMTfNCwpgmo4BUk-P0YLkMzrN6J7N2KRfYB34_PnsKTm4kZ09I6vFtDAvCNU6CFUo8EKz5kqx1AUKkwBKB5wn0qhFtmtOiJUt0o69QiZx6awJESPfxJZvWmSroT6tipNcQbeBTBVXV2sbnRZ3Awz7AUBkV1NEgWRBGAHFu5IC9R68kUrs9Q3YF1YQW5rrOsrFnO0lStBsammiS4cXT29aGblm8-1aCGKrn2fxQgJa5G0zjAtgzmFhpudIA653EAjht8jzSt6ahXwfHXsmWkQuSWJDgFXbl0eK_KSs3i5DD732l_9-rQ2yDiIZ7w5HO6_IXdxPGfcL22R1fnZuXpPb6sc8n529sVqHkq83LZy_AR81vgE |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=miRNA-Dependent+CD4%5Bsup.%2B%5D+T+Cell+Differentiation+in+the+Pathogenesis+of+Multiple+Sclerosis&rft.jtitle=Multiple+sclerosis+international&rft.au=Basak%2C+Justyna&rft.au=Majsterek%2C+Ireneusz&rft.date=2021-01-08&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=2090-2654&rft.volume=2021&rft_id=info:doi/10.1155%2F2021%2F8825588&rft.externalDocID=A696726892 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2090-2654&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2090-2654&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2090-2654&client=summon |